The NIH archives of the Human Genome Project could fall victim to Trump administration cuts, writes a former archivist.

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

From STAT’s Adam Feuerstein: Another example of why biotech is a tough business.

HHS Secretary Robert F. Kennedy Jr. said that the FDA would look for ways to fast-track approval for rare disease treatments ...

While overall risk of macular degeneration remained low, a study suggests that GLP-1 drugs may have increased that risk in ...

It looks like the NIH is thinking about AI differently than the FDA, who earlier this week released a “rushed” AI tool across ...

Merck, as it prepares a new version of its cancer blockbuster Keytruda, gets a boost in its patent dispute with Halozyme ...

An Otsuka drug succeeded in a Phase 3 study in a chronic kidney disease, with results that outperformed a competitor's recent ...

WASHINGTON — President Trump declared Medicare off-limits several months ago, but Republicans are now considering ways to ...

From 2020 to 2024, universities contributed patents underpinning 50% of FDA-approved drugs. 87% of those academic ...

After becoming popular in the wake of the Me Too movement, at-home sexual assault kits are still facing legal battles. Things ...

Novo Nordisk’s stock has tumbled over 50% since its peak around a year ago, and it just ousted its CEO. Former employees say ...